All episodes
Medical Forecasting - Part 2
Medical Forecasting - Part 1
Understanding Amyloidosis
Uncertainties Regarding Cerebral Palsy Diagnosis - Part 2
Distinguishing Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer Disease
Uncertainties Regarding Cerebral Palsy Diagnosis - Part 1
CMS Releases Final 2025 Physician Fee Schedule - Part 3
CMS Releases Final 2025 Physician Fee Schedule - Part 2
CMS Releases Final 2025 Physician Fee Schedule - Part 1
Understanding Acute Symptomatic Seizures
Features of Educational Social Media Posts - Part 2
Features of Educational Social Media Posts - Part 1
Hereditary Ataxia SCA27B
Long-Term Outcomes and Rehabilitation in Anti-NMDAR Encephalitis - Part 2
Long-Term Outcomes and Rehabilitation in Anti-NMDAR Encephalitis - Part 2
Long-Term Outcomes and Rehabilitation in Anti-NMDAR Encephalitis - Part 1
Myelitis Associated With Rheumatologic Disease - Part 2
Myelitis Associated With Rheumatologic Disease - Part 1
Could GLP-1 Receptor Agonists Reduce the Risk of Neurologic Disorders?
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 3
The Placebo Effect
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 2
CAA-RI and Biopsy-Positive Primary Angiitis of the CNS - Part 1
Lab Minute - Vitamin D
Could Reducing Environmental Toxins Help Mitigate the Risk for Parkinson's Disease? Where the Evidence Is Leading
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 3
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 2
Genetic Leukodystrophies Mimicking CNS Inflammation - Part 1
Early Treatment Cuts Relapse Risk in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease
Interventions for the Acute Management of Migraine Episodes in Adults - Part 3
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders
Interventions for the Acute Management of Migraine Episodes in Adults - Part 2
Interventions for the Acute Management of Migraine Episodes in Adults - Part 1
Timing of Anticoagulation Resumption and Risk of Ischemic and Hemorrhagic Complications in Patients With ICH and Mechanical Heart Valves
Women History Minute - The Women of the Cajal School
Revised Criteria for Diagnosis and Staging of Alzheimer Disease
End-of-Life Health Care Service Use and Cost
Women History Minute - Cecile Vogt
Neurology on the Hill
A Comparison of Side Effects for Four First-line Antiseizure Medications
Epilepsy in Patients With Primary CNS Lymphoma
The Rise of the Science Sleuths - Part 3
Lab Minute - B Vitamins
Lab Minute - ACE levels
How to Respond to a Request for Hastened Death from a Person Living with Neurologic Illness
The Rise of the Science Sleuths - Part 2
The Rise of the Science Sleuths - Part 1
Lab Minute - Thyroid Antibodies
Lab Minute - IgG4
Deep Brain Stimulation of Symptom-Specific Networks in Parkinson Disease - Part 2
Global Burden of Neurologic Conditions
Deep Brain Stimulation of Symptom-Specific Networks in Parkinson Disease - Part 1
Lab Minute - Iron
What Neurologist Should Know About Antidepressants, Weight Gain for Neuropathy
The Topic of Neurological Care for Transgender Patients - Part 3
Relapsing-Remitting Immunotherapy Responsive SFN
Gender Discrepancies in Leadership Roles and Recognition Awards in the Child Neurology Society
The Topic of Neurological Care for Transgender Patients - Part 2
The Topic of Neurological Care for Transgender Patients - Part 1
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders - Part 2
A General Neurologist's Practical Diagnostic Algorithm for Atypical Parkinsonian Disorders - Part 1
CMAP and Myosin-Loss Pathology in Patients With Critical Illness Myopathy
Improving Clinical Documentation Efficiency with AI
Monoclonal Antibody to PACAP for Migraine Prevention - Part 2
Depression During Intern Year Increases Risk for Persistent MD Depression: What Can Training Programs Do to Intervene
Monoclonal Antibody to PACAP for Migraine Prevention - Part 1
Association of Extent of TSS With Cerebral Glymphatic Clearance in Patients With IIH
Effect of Ubrogepant on Patient-Reported Outcomes When Administered During the Migraine Prodrome
Large Study Finds COVID Vaccination Does Not Increase Multiple Sclerosis Relapses
Spinal Muscular Atrophy Update in Best Practices - Part 3
Specialist Physiotherapy for Functional Motor Disorder
Spinal Muscular Atrophy Update in Best Practices - Part 2
Spinal Muscular Atrophy Update in Best Practice - Part 1
Blood Biomarkers to Detect Alzheimer Disease - Part 2
Outcomes of Patients With MCI With Lewy Bodies or Alzheimer Disease - Part 2
Blood Biomarkers to Detect Alzheimer Disease - Part 1
Blood Biomarkers to Detect Alzheimer Disease - Part 1
Outcomes of Patients With MCI With Lewy Bodies or Alzheimer Disease - Part 1
New Treatment Option for Parkinson Disease
Chronic Adaptive Deep Brain Stimulation Versus Conventional Stimulation in Parkinson Disease
Efficacy of Atogepant in Chronic Migraine With and Without Acute Medication Overuse
Neuropsychological Profiles of Deployment-Related mTBI
Long-Term Dementia Risk in Parkinson Disease - Part 1
Interpreting DAT Imaging Results in the Clinical Context - Part 2
Understanding Long COVID - Part 2
Understanding Long COVID - Part 1
Interpreting DAT Imaging Results in the Clinical Context
New Data and New Controversies on Cardiac Monitoring and Anticoagulation - Part 1
AHS Position Statement
Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core - Part 2
Transient Smartphone Blindness
Bridging Therapy With Tenecteplase or Alteplase in Patients With Large Ischemic Core
The Ethical Landscape of Prodromal Parkinson Disease
Movement Disorders Emergencies - Part 3
Movement Disorders Emergencies - Part 2
Movement Disorders Emergencies - Part 1
Association of Prenatal Exposure to Antiseizure Medications
Tapping the Brakes on New Parkinson Disease Biological Staging
Biologic Therapies Approved for the Treatment of Generalized Myasthenia Gravis - Part 2
Large Language Models for Quality and Efficiency of Neurologic Care - Part 2